CN Stock MarketDetailed Quotes

688289 Sansure Biotech Inc.

Watchlist
  • 20.88
  • -0.43-2.02%
Market Closed Jan 3 15:00 CST
12.16BMarket Cap46.92P/E (TTM)

Sansure Biotech Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
27.60%4.42B
73.49%4.32B
76.66%4.33B
31.78%4.23B
40.91%3.46B
12.89%2.49B
-20.32%2.45B
21.86%3.21B
4.49%2.46B
-33.91%2.2B
Transactional financial assets
-88.85%150.74M
-83.09%402.83M
-79.54%617.21M
-77.63%548.28M
-53.58%1.35B
-18.05%2.38B
51.91%3.02B
19.78%2.45B
14.24%2.91B
311.03%2.91B
Notes receivable and accounts receivable
-21.46%611.98M
-23.14%675.07M
-35.85%669.05M
-46.67%692.26M
-17.48%779.2M
-4.98%878.31M
18.72%1.04B
60.74%1.3B
29.81%944.25M
41.11%924.3M
-Notes receivable
696.56%3.43M
756.51%8.16M
258.48%7.5M
-87.57%2.71M
-92.49%430.08K
-88.64%952.32K
-72.02%2.09M
68.76%21.79M
-81.88%5.73M
-72.59%8.38M
-Accounts receivable
-21.86%608.56M
-23.99%666.91M
-36.45%661.55M
-45.97%689.55M
-17.02%778.77M
-4.21%877.36M
19.50%1.04B
60.61%1.28B
34.89%938.52M
46.67%915.92M
Other receivables (including interest and dividends)
-64.75%25.81M
-46.22%40.44M
-72.49%27.79M
-71.49%23.49M
128.55%73.22M
120.72%75.2M
541.48%101.02M
476.44%82.41M
47.67%32.04M
145.27%34.07M
-Other receivable
----
-46.22%40.44M
----
-71.49%23.49M
----
120.72%75.2M
----
522.21%82.41M
----
185.80%34.07M
Contractual assets
----
----
----
----
----
----
----
----
--71.71K
--71.71K
Advance payment
41.52%95.1M
-16.75%56.59M
15.50%55.41M
-41.81%53.68M
-61.94%67.2M
-33.05%67.97M
-63.58%47.98M
27.91%92.24M
306.40%176.57M
47.63%101.53M
Inventories
24.55%419.03M
15.43%391.97M
11.18%385.5M
6.00%376.63M
-39.49%336.43M
-39.83%339.58M
-24.83%346.72M
-3.84%355.31M
27.50%556M
40.11%564.33M
Other current assets
30.07%21.97M
-33.42%21.94M
-41.38%24.74M
-35.20%21.77M
-14.17%16.89M
-21.50%32.95M
25.13%42.21M
68.23%33.59M
18.40%19.68M
225.90%41.97M
Total current assets
-5.65%5.74B
-5.75%5.9B
-13.32%6.11B
-20.94%5.95B
-14.24%6.09B
-7.57%6.26B
7.08%7.05B
26.13%7.53B
15.49%7.1B
30.47%6.78B
Non Current assets
Debt investment
2.91%3.19M
2.93%3.17M
2,946.59%93.03M
2,968.16%93.01M
--3.1M
--3.08M
--3.05M
--3.03M
----
----
Other equity investment
-45.78%248.18M
-50.80%229.18M
-88.01%42.18M
-44.03%201.25M
64.10%457.7M
70.92%465.8M
36.32%351.86M
39.72%359.58M
138.98%278.91M
151.04%272.54M
Other non-current financial assets
0.00%470.96M
--470.96M
--470.96M
--470.96M
--470.96M
----
----
----
----
----
Investment real estate
----
----
----
----
----
----
----
-5.76%63.04K
-38.80%63.41K
-38.37%64.57K
Fixed assets
----
95.71%1.01B
----
106.31%1.01B
----
1.20%515.36M
----
37.67%488.84M
----
71.87%509.24M
Constru in process
----
-98.96%3.46M
----
-98.28%4.59M
----
138.79%332.29M
----
142.42%267.76M
----
234.04%139.15M
Intangible assets
240.17%343.38M
169.87%278.55M
252.64%278.86M
258.03%283.28M
33.02%100.94M
132.09%103.22M
75.46%79.08M
73.69%79.12M
11.86%75.89M
-35.10%44.47M
Development expenditure
211.59%85.16M
293.54%66.4M
585.81%53.21M
739.93%44.68M
--27.33M
--16.87M
--7.76M
--5.32M
----
----
Goodwill
8.58%7.66M
8.08%7.66M
--7.66M
--7.66M
--7.06M
--7.09M
----
----
----
----
Long deferred expense
7.96%44.66M
15.87%49.58M
4.60%49.1M
26.57%52.37M
70.16%41.37M
190.20%42.79M
198.01%46.94M
154.43%41.38M
29.51%24.31M
-7.79%14.74M
Deferred tax assets
2.42%65.57M
0.88%67.47M
7.37%72.58M
6.04%73.82M
88.65%64.02M
120.10%66.88M
178.87%67.59M
178.52%69.62M
59.68%33.94M
68.07%30.39M
Usufruct assets
2.90%25.75M
-24.54%22.03M
3.00%26.85M
5.27%30.17M
-6.74%25.03M
23.36%29.19M
60.39%26.06M
85.11%28.66M
65.54%26.83M
27.46%23.66M
Other non current assets
33.02%28.82M
502.91%67.95M
225.25%34.54M
148.46%25.16M
-48.29%21.66M
-63.23%11.27M
-26.10%10.62M
-76.46%10.13M
-20.48%41.89M
-94.85%30.65M
Total non current assets
27.35%2.83B
37.88%2.73B
57.10%2.64B
51.95%2.5B
48.04%2.22B
44.69%1.98B
36.67%1.68B
46.63%1.65B
62.30%1.5B
17.41%1.37B
Total assets
3.17%8.57B
4.73%8.63B
0.21%8.75B
-7.84%8.45B
-3.37%8.31B
1.20%8.24B
11.73%8.73B
29.38%9.17B
21.61%8.6B
28.07%8.14B
Liabilities
Current liabilities
Short term loan
--9M
--9M
--9M
--9M
----
----
----
----
----
----
Notes payable and accounts payable
7.71%421.35M
-21.34%358.36M
-28.64%410.27M
-33.56%525.78M
1.62%391.2M
-10.04%455.61M
47.73%574.93M
205.92%791.41M
35.21%384.97M
94.99%506.48M
-Notes payable
-5.93%19.99M
--9.61M
1,769.92%44.88M
--57.13M
--21.26M
----
--2.4M
----
----
----
-Accounts payable
8.49%401.36M
-23.45%348.75M
-36.18%365.39M
-40.78%468.65M
-3.90%369.94M
-10.04%455.61M
47.12%572.53M
205.92%791.41M
35.21%384.97M
94.99%506.48M
Contract liabilities
-18.92%27.25M
-26.29%26.45M
-34.37%29M
-38.23%32.81M
-72.81%33.61M
-39.36%35.89M
-59.90%44.19M
-32.47%53.11M
65.92%123.59M
4.46%59.19M
Salaries payable
-24.07%128.19M
-30.00%133.28M
-31.05%137.61M
-33.92%197.93M
50.69%168.83M
67.79%190.4M
54.75%199.59M
82.74%299.52M
-11.07%112.04M
-23.20%113.47M
Taxs payable
-73.78%12.41M
-61.28%26.35M
-96.44%3.58M
-77.65%48.35M
-36.07%47.33M
-16.53%68.06M
89.19%100.77M
113.56%216.36M
-37.27%74.04M
-14.30%81.55M
Other payable (including interest and dividends)
-11.81%106.35M
-29.87%106.97M
-22.67%119.86M
-52.25%93.39M
41.63%120.59M
159.29%152.53M
136.21%154.99M
287.30%195.57M
92.67%85.15M
84.81%58.82M
-Other payable
----
-29.87%106.97M
----
-52.25%93.39M
----
159.29%152.53M
----
287.30%195.57M
----
84.81%58.82M
Non current liabilities due within one year
-3.62%9.21M
4.10%10.14M
-11.79%10.92M
-22.15%11.1M
-31.75%9.56M
-21.47%9.74M
23.30%12.38M
67.95%14.26M
--14M
--12.41M
Other current liabilities
-21.91%508.92K
-35.89%477.02K
-38.66%608.61K
-46.78%796.44K
-84.32%651.68K
-70.97%744.1K
-71.21%992.12K
-37.44%1.5M
9.54%4.16M
36.04%2.56M
Total current liabilities
-7.45%714.28M
-26.50%671.04M
-33.73%720.86M
-41.52%919.15M
-3.28%771.77M
9.41%912.98M
43.00%1.09B
136.73%1.57B
22.53%797.95M
40.72%834.49M
Current liabilities
Long term account payable
----
----
----
----
----
--11.09M
----
----
----
----
Estimate liabilities
----
----
----
----
--478.65K
--506.53K
--1.78M
--26.09M
----
----
Deferred tax liabilities
-8.94%55.32M
126.16%56.53M
153.15%57.23M
212.14%59.45M
299.32%60.75M
57.58%24.99M
73.06%22.61M
46.39%19.04M
25.98%15.21M
48.15%15.86M
Long term deferred income
3.11%31.22M
4.46%31.65M
5.60%32.19M
6.41%32.49M
-22.74%30.28M
-23.56%30.3M
-24.05%30.48M
18.90%30.53M
54.32%39.19M
142.93%39.63M
Lease liabilities
52.51%16.55M
-12.45%13.08M
56.39%15.81M
33.93%18.21M
-12.67%10.85M
46.42%14.94M
76.80%10.11M
112.22%13.6M
-23.32%12.42M
-42.28%10.2M
Total non current liabilities
371.29%503.85M
507.21%496.81M
662.71%495.58M
23.39%110.14M
59.98%106.91M
24.54%81.82M
10.29%64.98M
97.95%89.26M
24.51%66.83M
46.99%65.7M
Total liabilities
38.63%1.22B
17.40%1.17B
5.52%1.22B
-38.03%1.03B
1.61%878.68M
10.51%994.8M
40.65%1.15B
134.26%1.66B
22.68%864.77M
41.16%900.18M
Shareholders equity
Paid-in capital
-0.86%583.39M
0.00%588.46M
0.00%588.46M
0.00%588.46M
0.00%588.46M
0.00%588.46M
47.11%588.46M
47.11%588.46M
47.11%588.46M
47.11%588.46M
Capital reserve funds
-8.44%1.75B
-1.40%1.9B
-1.25%1.89B
-0.32%1.91B
-2.00%1.91B
-0.09%1.93B
-7.89%1.92B
-7.33%1.91B
-5.15%1.95B
-6.11%1.93B
Surplus reserve funds
0.00%294.23M
0.00%294.23M
0.00%294.23M
0.00%294.23M
12.42%294.23M
12.42%294.23M
12.42%294.23M
12.42%294.23M
0.00%261.73M
0.00%261.73M
Retained profit
-4.73%4.88B
1.43%4.99B
-3.36%4.96B
-3.83%4.88B
-2.76%5.13B
2.50%4.92B
14.86%5.14B
32.91%5.08B
45.06%5.27B
60.06%4.8B
Less:Treasury stock
-40.58%305.95M
-8.16%472.81M
20.43%472.81M
31.26%515.33M
35.45%514.84M
39.26%514.84M
50.94%392.6M
96.29%392.6M
--380.11M
--369.7M
Other composite income
212.14%33.82M
98.59%39.12M
135.84%41.35M
123.41%43.26M
-64.37%10.83M
-21.02%19.7M
-24.25%17.53M
-10.81%19.36M
114.44%30.41M
243.84%24.94M
Attributable parent company shareholders equity adjustment items
----
----
----
----
----
----
--0.01
----
----
----
Shareholders equity without minority interests
-2.38%7.24B
1.45%7.34B
-3.34%7.31B
-3.99%7.2B
-3.96%7.41B
0.01%7.23B
8.35%7.56B
17.77%7.5B
21.31%7.72B
26.41%7.23B
Minority interests
701.62%114.96M
751.70%126.26M
1,711.99%219.84M
1,739.71%223.64M
21.92%14.34M
25.19%14.82M
-1.07%12.13M
-2.23%12.16M
--11.76M
--11.84M
Total shareholder equity
-1.02%7.35B
2.99%7.46B
-0.60%7.53B
-1.17%7.42B
-3.92%7.43B
0.05%7.25B
8.33%7.57B
17.73%7.51B
21.49%7.73B
26.62%7.24B
Total liabilityies and equity
3.17%8.57B
4.73%8.63B
0.21%8.75B
-7.84%8.45B
-3.37%8.31B
1.20%8.24B
11.73%8.73B
29.38%9.17B
21.61%8.6B
28.07%8.14B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 27.60%4.42B73.49%4.32B76.66%4.33B31.78%4.23B40.91%3.46B12.89%2.49B-20.32%2.45B21.86%3.21B4.49%2.46B-33.91%2.2B
Transactional financial assets -88.85%150.74M-83.09%402.83M-79.54%617.21M-77.63%548.28M-53.58%1.35B-18.05%2.38B51.91%3.02B19.78%2.45B14.24%2.91B311.03%2.91B
Notes receivable and accounts receivable -21.46%611.98M-23.14%675.07M-35.85%669.05M-46.67%692.26M-17.48%779.2M-4.98%878.31M18.72%1.04B60.74%1.3B29.81%944.25M41.11%924.3M
-Notes receivable 696.56%3.43M756.51%8.16M258.48%7.5M-87.57%2.71M-92.49%430.08K-88.64%952.32K-72.02%2.09M68.76%21.79M-81.88%5.73M-72.59%8.38M
-Accounts receivable -21.86%608.56M-23.99%666.91M-36.45%661.55M-45.97%689.55M-17.02%778.77M-4.21%877.36M19.50%1.04B60.61%1.28B34.89%938.52M46.67%915.92M
Other receivables (including interest and dividends) -64.75%25.81M-46.22%40.44M-72.49%27.79M-71.49%23.49M128.55%73.22M120.72%75.2M541.48%101.02M476.44%82.41M47.67%32.04M145.27%34.07M
-Other receivable -----46.22%40.44M-----71.49%23.49M----120.72%75.2M----522.21%82.41M----185.80%34.07M
Contractual assets ----------------------------------71.71K--71.71K
Advance payment 41.52%95.1M-16.75%56.59M15.50%55.41M-41.81%53.68M-61.94%67.2M-33.05%67.97M-63.58%47.98M27.91%92.24M306.40%176.57M47.63%101.53M
Inventories 24.55%419.03M15.43%391.97M11.18%385.5M6.00%376.63M-39.49%336.43M-39.83%339.58M-24.83%346.72M-3.84%355.31M27.50%556M40.11%564.33M
Other current assets 30.07%21.97M-33.42%21.94M-41.38%24.74M-35.20%21.77M-14.17%16.89M-21.50%32.95M25.13%42.21M68.23%33.59M18.40%19.68M225.90%41.97M
Total current assets -5.65%5.74B-5.75%5.9B-13.32%6.11B-20.94%5.95B-14.24%6.09B-7.57%6.26B7.08%7.05B26.13%7.53B15.49%7.1B30.47%6.78B
Non Current assets
Debt investment 2.91%3.19M2.93%3.17M2,946.59%93.03M2,968.16%93.01M--3.1M--3.08M--3.05M--3.03M--------
Other equity investment -45.78%248.18M-50.80%229.18M-88.01%42.18M-44.03%201.25M64.10%457.7M70.92%465.8M36.32%351.86M39.72%359.58M138.98%278.91M151.04%272.54M
Other non-current financial assets 0.00%470.96M--470.96M--470.96M--470.96M--470.96M--------------------
Investment real estate -----------------------------5.76%63.04K-38.80%63.41K-38.37%64.57K
Fixed assets ----95.71%1.01B----106.31%1.01B----1.20%515.36M----37.67%488.84M----71.87%509.24M
Constru in process -----98.96%3.46M-----98.28%4.59M----138.79%332.29M----142.42%267.76M----234.04%139.15M
Intangible assets 240.17%343.38M169.87%278.55M252.64%278.86M258.03%283.28M33.02%100.94M132.09%103.22M75.46%79.08M73.69%79.12M11.86%75.89M-35.10%44.47M
Development expenditure 211.59%85.16M293.54%66.4M585.81%53.21M739.93%44.68M--27.33M--16.87M--7.76M--5.32M--------
Goodwill 8.58%7.66M8.08%7.66M--7.66M--7.66M--7.06M--7.09M----------------
Long deferred expense 7.96%44.66M15.87%49.58M4.60%49.1M26.57%52.37M70.16%41.37M190.20%42.79M198.01%46.94M154.43%41.38M29.51%24.31M-7.79%14.74M
Deferred tax assets 2.42%65.57M0.88%67.47M7.37%72.58M6.04%73.82M88.65%64.02M120.10%66.88M178.87%67.59M178.52%69.62M59.68%33.94M68.07%30.39M
Usufruct assets 2.90%25.75M-24.54%22.03M3.00%26.85M5.27%30.17M-6.74%25.03M23.36%29.19M60.39%26.06M85.11%28.66M65.54%26.83M27.46%23.66M
Other non current assets 33.02%28.82M502.91%67.95M225.25%34.54M148.46%25.16M-48.29%21.66M-63.23%11.27M-26.10%10.62M-76.46%10.13M-20.48%41.89M-94.85%30.65M
Total non current assets 27.35%2.83B37.88%2.73B57.10%2.64B51.95%2.5B48.04%2.22B44.69%1.98B36.67%1.68B46.63%1.65B62.30%1.5B17.41%1.37B
Total assets 3.17%8.57B4.73%8.63B0.21%8.75B-7.84%8.45B-3.37%8.31B1.20%8.24B11.73%8.73B29.38%9.17B21.61%8.6B28.07%8.14B
Liabilities
Current liabilities
Short term loan --9M--9M--9M--9M------------------------
Notes payable and accounts payable 7.71%421.35M-21.34%358.36M-28.64%410.27M-33.56%525.78M1.62%391.2M-10.04%455.61M47.73%574.93M205.92%791.41M35.21%384.97M94.99%506.48M
-Notes payable -5.93%19.99M--9.61M1,769.92%44.88M--57.13M--21.26M------2.4M------------
-Accounts payable 8.49%401.36M-23.45%348.75M-36.18%365.39M-40.78%468.65M-3.90%369.94M-10.04%455.61M47.12%572.53M205.92%791.41M35.21%384.97M94.99%506.48M
Contract liabilities -18.92%27.25M-26.29%26.45M-34.37%29M-38.23%32.81M-72.81%33.61M-39.36%35.89M-59.90%44.19M-32.47%53.11M65.92%123.59M4.46%59.19M
Salaries payable -24.07%128.19M-30.00%133.28M-31.05%137.61M-33.92%197.93M50.69%168.83M67.79%190.4M54.75%199.59M82.74%299.52M-11.07%112.04M-23.20%113.47M
Taxs payable -73.78%12.41M-61.28%26.35M-96.44%3.58M-77.65%48.35M-36.07%47.33M-16.53%68.06M89.19%100.77M113.56%216.36M-37.27%74.04M-14.30%81.55M
Other payable (including interest and dividends) -11.81%106.35M-29.87%106.97M-22.67%119.86M-52.25%93.39M41.63%120.59M159.29%152.53M136.21%154.99M287.30%195.57M92.67%85.15M84.81%58.82M
-Other payable -----29.87%106.97M-----52.25%93.39M----159.29%152.53M----287.30%195.57M----84.81%58.82M
Non current liabilities due within one year -3.62%9.21M4.10%10.14M-11.79%10.92M-22.15%11.1M-31.75%9.56M-21.47%9.74M23.30%12.38M67.95%14.26M--14M--12.41M
Other current liabilities -21.91%508.92K-35.89%477.02K-38.66%608.61K-46.78%796.44K-84.32%651.68K-70.97%744.1K-71.21%992.12K-37.44%1.5M9.54%4.16M36.04%2.56M
Total current liabilities -7.45%714.28M-26.50%671.04M-33.73%720.86M-41.52%919.15M-3.28%771.77M9.41%912.98M43.00%1.09B136.73%1.57B22.53%797.95M40.72%834.49M
Current liabilities
Long term account payable ----------------------11.09M----------------
Estimate liabilities ------------------478.65K--506.53K--1.78M--26.09M--------
Deferred tax liabilities -8.94%55.32M126.16%56.53M153.15%57.23M212.14%59.45M299.32%60.75M57.58%24.99M73.06%22.61M46.39%19.04M25.98%15.21M48.15%15.86M
Long term deferred income 3.11%31.22M4.46%31.65M5.60%32.19M6.41%32.49M-22.74%30.28M-23.56%30.3M-24.05%30.48M18.90%30.53M54.32%39.19M142.93%39.63M
Lease liabilities 52.51%16.55M-12.45%13.08M56.39%15.81M33.93%18.21M-12.67%10.85M46.42%14.94M76.80%10.11M112.22%13.6M-23.32%12.42M-42.28%10.2M
Total non current liabilities 371.29%503.85M507.21%496.81M662.71%495.58M23.39%110.14M59.98%106.91M24.54%81.82M10.29%64.98M97.95%89.26M24.51%66.83M46.99%65.7M
Total liabilities 38.63%1.22B17.40%1.17B5.52%1.22B-38.03%1.03B1.61%878.68M10.51%994.8M40.65%1.15B134.26%1.66B22.68%864.77M41.16%900.18M
Shareholders equity
Paid-in capital -0.86%583.39M0.00%588.46M0.00%588.46M0.00%588.46M0.00%588.46M0.00%588.46M47.11%588.46M47.11%588.46M47.11%588.46M47.11%588.46M
Capital reserve funds -8.44%1.75B-1.40%1.9B-1.25%1.89B-0.32%1.91B-2.00%1.91B-0.09%1.93B-7.89%1.92B-7.33%1.91B-5.15%1.95B-6.11%1.93B
Surplus reserve funds 0.00%294.23M0.00%294.23M0.00%294.23M0.00%294.23M12.42%294.23M12.42%294.23M12.42%294.23M12.42%294.23M0.00%261.73M0.00%261.73M
Retained profit -4.73%4.88B1.43%4.99B-3.36%4.96B-3.83%4.88B-2.76%5.13B2.50%4.92B14.86%5.14B32.91%5.08B45.06%5.27B60.06%4.8B
Less:Treasury stock -40.58%305.95M-8.16%472.81M20.43%472.81M31.26%515.33M35.45%514.84M39.26%514.84M50.94%392.6M96.29%392.6M--380.11M--369.7M
Other composite income 212.14%33.82M98.59%39.12M135.84%41.35M123.41%43.26M-64.37%10.83M-21.02%19.7M-24.25%17.53M-10.81%19.36M114.44%30.41M243.84%24.94M
Attributable parent company shareholders equity adjustment items --------------------------0.01------------
Shareholders equity without minority interests -2.38%7.24B1.45%7.34B-3.34%7.31B-3.99%7.2B-3.96%7.41B0.01%7.23B8.35%7.56B17.77%7.5B21.31%7.72B26.41%7.23B
Minority interests 701.62%114.96M751.70%126.26M1,711.99%219.84M1,739.71%223.64M21.92%14.34M25.19%14.82M-1.07%12.13M-2.23%12.16M--11.76M--11.84M
Total shareholder equity -1.02%7.35B2.99%7.46B-0.60%7.53B-1.17%7.42B-3.92%7.43B0.05%7.25B8.33%7.57B17.73%7.51B21.49%7.73B26.62%7.24B
Total liabilityies and equity 3.17%8.57B4.73%8.63B0.21%8.75B-7.84%8.45B-3.37%8.31B1.20%8.24B11.73%8.73B29.38%9.17B21.61%8.6B28.07%8.14B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)------China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Virus Testing
Virus Testing
Intraday-0.31%
The Concept of in Vitro Diagnosis
The Concept of in Vitro Diagnosis
Intraday-0.71%
Biomedical
Biomedical
Intraday-1.08%